Benzinga | Oct 26, 2021 07:05AM EDT

Myovant Sciences Q2 EPS $(0.23) Beats $(0.38) Estimate, Sales $77.90M Beat $71.40M Estimate

Myovant Sciences (NYSE:MYOV) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.38) by 39.47 percent. This is a 69.33 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $77.90 million which beat the analyst consensus estimate of $71.40 million by 9.11 percent.